635 related articles for article (PubMed ID: 19120365)
41. Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy.
Ngan BY; Forte V; Campisi P
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1170-6. PubMed ID: 19015446
[TBL] [Abstract][Full Text] [Related]
42. [The effect of pro-angiogenic factors and their receptors on angiogenesis in hepatocellular carcinoma].
Zhao ZC; Zheng SS; Wan YL; Jia CK; Li JJ; Gu JR; Guo BL
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):472-5. PubMed ID: 15555336
[TBL] [Abstract][Full Text] [Related]
43. Vascular composition, apoptosis, and expression of angiogenic factors in the corpus luteum during prostaglandin F2alpha-induced regression in sheep.
Vonnahme KA; Redmer DA; Borowczyk E; Bilski JJ; Luther JS; Johnson ML; Reynolds LP; Grazul-Bilska AT
Reproduction; 2006 Jun; 131(6):1115-26. PubMed ID: 16735551
[TBL] [Abstract][Full Text] [Related]
44. Localization of the VEGF and angiopoietin genes in uterine carcinosarcoma.
Emoto M; Charnock-Jones DS; Licence DR; Ishiguro M; Kawai M; Yanaihara A; Saito T; Hachisuga T; Iwasaki H; Kawarabayashi T; Smith SK
Gynecol Oncol; 2004 Dec; 95(3):474-82. PubMed ID: 15581949
[TBL] [Abstract][Full Text] [Related]
45. Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization.
Bogdanovic E; Nguyen VP; Dumont DJ
J Cell Sci; 2006 Sep; 119(Pt 17):3551-60. PubMed ID: 16895971
[TBL] [Abstract][Full Text] [Related]
46. Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition.
Daly C; Eichten A; Castanaro C; Pasnikowski E; Adler A; Lalani AS; Papadopoulos N; Kyle AH; Minchinton AI; Yancopoulos GD; Thurston G
Cancer Res; 2013 Jan; 73(1):108-18. PubMed ID: 23149917
[TBL] [Abstract][Full Text] [Related]
47. Alterations in expression of angiopoietins and the Tie-2 receptor in the retina of streptozotocin induced diabetic rats.
Ohashi H; Takagi H; Koyama S; Oh H; Watanabe D; Antonetti DA; Matsubara T; Nagai K; Arai H; Kita T; Honda Y
Mol Vis; 2004 Aug; 10():608-17. PubMed ID: 15354084
[TBL] [Abstract][Full Text] [Related]
48. Expressions and clinical significances of angiopoietin-1, -2 and Tie2 in human gastric cancer.
Wang J; Wu K; Zhang D; Tang H; Xie H; Hong L; Pan Y; Lan M; Hu S; Ning X; Fan D
Biochem Biophys Res Commun; 2005 Nov; 337(1):386-93. PubMed ID: 16185665
[TBL] [Abstract][Full Text] [Related]
49. Sequential induction of angiogenic growth factors by TNF-alpha in choroidal endothelial cells.
Hangai M; He S; Hoffmann S; Lim JI; Ryan SJ; Hinton DR
J Neuroimmunol; 2006 Feb; 171(1-2):45-56. PubMed ID: 16288810
[TBL] [Abstract][Full Text] [Related]
50. The roles of vascular endothelial growth factor and angiopoietin-2 in the regression of pregnancy pyogenic granuloma.
Yuan K; Lin MT
Oral Dis; 2004 May; 10(3):179-85. PubMed ID: 15089929
[TBL] [Abstract][Full Text] [Related]
51. The frequency of B- and T-cell gene rearrangements and epstein-barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations.
Tan BT; Warnke RA; Arber DA
J Mol Diagn; 2006 Sep; 8(4):466-75; quiz 527. PubMed ID: 16931587
[TBL] [Abstract][Full Text] [Related]
52. Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma.
Zhang ZL; Liu ZS; Sun Q
World J Gastroenterol; 2006 Jul; 12(26):4241-5. PubMed ID: 16830384
[TBL] [Abstract][Full Text] [Related]
53. Morphologic and immunophenotypic analysis of angioimmunoblastic T-cell lymphoma: Emphasis on phenotypic aberrancies for early diagnosis.
Merchant SH; Amin MB; Viswanatha DS
Am J Clin Pathol; 2006 Jul; 126(1):29-38. PubMed ID: 16753608
[TBL] [Abstract][Full Text] [Related]
54. Expression of vascular endothelial growth factor and angiopoietins in human corpus cavernosum.
Tomada N; Tomada I; Vendeira P; Neves D
BJU Int; 2010 Jan; 105(2):269-73. PubMed ID: 19583734
[TBL] [Abstract][Full Text] [Related]
55. Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF.
Maffei R; Martinelli S; Castelli I; Santachiara R; Zucchini P; Fontana M; Fiorcari S; Bonacorsi G; Ilariucci F; Torelli G; Marasca R
Leuk Res; 2010 Mar; 34(3):312-21. PubMed ID: 19616847
[TBL] [Abstract][Full Text] [Related]
56. Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering.
Davis S; Papadopoulos N; Aldrich TH; Maisonpierre PC; Huang T; Kovac L; Xu A; Leidich R; Radziejewska E; Rafique A; Goldberg J; Jain V; Bailey K; Karow M; Fandl J; Samuelsson SJ; Ioffe E; Rudge JS; Daly TJ; Radziejewski C; Yancopoulos GD
Nat Struct Biol; 2003 Jan; 10(1):38-44. PubMed ID: 12469114
[TBL] [Abstract][Full Text] [Related]
57. Immunohistochemical and genetic analysis of Chinese nasal natural killer/T-cell lymphomas.
Li T; Zhang B; Ye Y; Yin H
Hum Pathol; 2006 Jan; 37(1):54-60. PubMed ID: 16360416
[TBL] [Abstract][Full Text] [Related]
58. [The diagnostic value of microsatellite LOH analysis and the prognostic relevance of angiogenic gene expression in urinary bladder cancer].
Szarvas T
Magy Onkol; 2009 Dec; 53(4):385-9. PubMed ID: 20071311
[TBL] [Abstract][Full Text] [Related]
59. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Nadar SK; Blann A; Beevers DG; Lip GY
J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
[TBL] [Abstract][Full Text] [Related]
60. Effects of tumor suppressor gene (p53) on brain tumor angiogenesis and expression of angiogenic modulators.
Tse V; Yung Y; Santarelli JG; Juan D; Hsiao M; Haas M; Harsh G; Silverberg G
Anticancer Res; 2004; 24(1):1-10. PubMed ID: 15015569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
